MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $99,591 | +5.6% | 28,577 | 0.0% | 0.00% | – |
Q1 2024 | $94,304 | -29.9% | 28,577 | -50.9% | 0.00% | – |
Q4 2023 | $134,481 | +79.1% | 58,217 | 0.0% | 0.00% | – |
Q3 2023 | $75,100 | -2.3% | 58,217 | 0.0% | 0.00% | – |
Q2 2023 | $76,846 | +87.8% | 58,217 | 0.0% | 0.00% | – |
Q1 2023 | $40,921 | -5.0% | 58,217 | 0.0% | 0.00% | – |
Q4 2022 | $43,070 | -17.2% | 58,217 | 0.0% | 0.00% | – |
Q3 2022 | $52,000 | -27.8% | 58,217 | 0.0% | 0.00% | – |
Q2 2022 | $72,000 | +10.8% | 58,217 | 0.0% | 0.00% | – |
Q1 2022 | $65,000 | -31.6% | 58,217 | 0.0% | 0.00% | – |
Q4 2021 | $95,000 | -30.7% | 58,217 | 0.0% | 0.00% | – |
Q3 2021 | $137,000 | -23.9% | 58,217 | 0.0% | 0.00% | – |
Q2 2021 | $180,000 | -8.2% | 58,217 | 0.0% | 0.00% | – |
Q1 2021 | $196,000 | -7.1% | 58,217 | 0.0% | 0.00% | – |
Q4 2020 | $211,000 | – | 58,217 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tejara Capital Ltd | 2,435,806 | $1,721,871 | 0.88% |
Monaco Asset Management SAM | 1,316,245 | $930,454 | 0.28% |
DAFNA Capital Management LLC | 1,096,513 | $775,125 | 0.23% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $5,205,921 | 0.22% |
Clearline Capital LP | 2,052,709 | $1,451,060 | 0.22% |
Rubric Capital Management LP | 10,366,120 | $7,327,810 | 0.19% |
Orbimed Advisors | 7,747,891 | $5,476,984 | 0.11% |
Rock Springs Capital Management LP | 6,244,897 | $4,414,518 | 0.10% |
683 Capital Management, LLC | 2,000,000 | $1,413,801 | 0.10% |
Privium Fund Management (UK) Ltd | 177,200 | $131,128 | 0.10% |